c-myc oncogene expression and cell proliferation in mixed oligo-astrocytoma
β Scribed by Moinak Banerjee; Amit K. Dinda; Subrata Sinha; Chitra Sarkar; Meera Mathur
- Publisher
- John Wiley and Sons
- Year
- 1996
- Tongue
- French
- Weight
- 438 KB
- Volume
- 65
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
β¦ Synopsis
Mixed gliomas (oligo-astrocytomas) are brain tumours with an admixture of 2 different cell populations: astrocytes and oligodendroglia. On the basis of histological features and behaviour, these tumours are classified as low-grade mixed gliomas (MG) and malignant mixed gliomas (MMG). We have studied the relationship between c-myc protein expression and cellular proliferation in this class of tumours. Using antibody c-33 for c-myc and PC-I0 for the proliferating cell nuclear antigen (PCNA), immunohistochemistry was performed on 14 MG and 9 MMG. PCNAwas increased in MMG as compared to MG in both astrocytic and oligodendroglial areas. However, more c-mycpositive cells were seen only in the astrocytic areas of MMG. Analysis of the relationship of c-rnyc and PCNA suggests that the correlation of c-myc with cellular proliferation is dependent on tissue type and differentiation status.
π SIMILAR VOLUMES
Expression of oncogenes in gastric cancer tissue was evaluated with immunohistochemical staining methods using monoclonal antibodies to products of the oncogenes. Rates of expression in gastric cancer tissue were 50% for c-myc, 72% for c-erb B,, and 56% for c-Ha-rus oncogenes. Expression of these on
An important positive regulator of the cell cycle, cyclin D1, is often amplified and overexpressed in malignancies. Cyclin D1 aberrations were analysed in grade II-IV astrocytomas by fluorescence in situ hybridization (FISH), mRNA in situ hybridization and immunohistochemistry. Proliferation activit
Temporal variations in the expression of the __ras__ oncogene, and its protein product, were investigated during hexamethylene bisacetamide (HMBA)βinduced differentiation of murine erythroleukaemic (MEL) cells. We highlight the fact that when comparisons were made between untreated, proliferating ce